EUVIMEDEUVIMED entdecken
Open Access

Effects of Systemic Peroxisome Proliferator-Activated Receptor Gamma Inhibition on Bone and Immune Cells in Aged Female Mice

Xingming Shi iD, Kehong Ding, Raysa Rosario, Ashwin Ajith, Yun Su, Sean Shaw, Meghan McGee-Lawrence, Xin-Yun Lu, Anatolij Horuzsko, Carlos M Isales

The Journals of Gerontology: Series A · 2024

DOI: 10.1093/gerona/glad247 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journals of Gerontology: Series A, 2024. Verfasst von Xingming Shi und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neuroscience and Regenerative Medicine, Augusta University, Augusta, Georgia, USA. Hauptthemen laut MEDLINE: Anilides, Osteogenesis, PPAR gamma. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS, NIH HHS, National Institute on Aging.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study investigates the effects of peroxisome proliferator-activated receptor gamma (PPARγ) inhibition on bone and immune cell profiles in aged female mice, as well as in vitro stromal stem cell osteogenic differentiation and inflammation gene expression. The hypothesis was that inhibition of PPARγ would increase bone mass and alter immune and other cellular functions. Our results showed that treatment with PPARγ antagonist GW9662 for 6 weeks reduced bone volume and trabecular number and increased trabecular spacing. However, inhibition of PPARγ had no significant effect on marrow and spleen immune cell composition in aged female mice. In vitro experiments indicated that GW9662 treatment increased the expression of osteogenic genes but did not affect adipogenic genes. Additionally, GW9662 treatment decreased the expression of several inflammation-related genes. Overall, these findings suggest that PPARγ inhibition may have adverse effects on bone in aged female mice.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AnilidesOsteogenesisPPAR gammaAnimalsFemaleMiceAdipogenesisInflammationBone and BonesAging

Stichwörter der Autor:innen

AgingBone lossHematopoietic skewPPARγ

Substanzen

2-chloro-5-nitrobenzanilideAnilidesPPAR gamma

Autor:innen und Institutionen

  • Department of Neuroscience and Regenerative Medicine, Augusta University, Augusta, Georgia, USA.
  • Center for Molecular Chaperone/Radiobiology and Cancer Virology, Augusta University, Augusta, Georgia, USA.
  • Department of Cellular Biology and Anatomy, Augusta University, Augusta, Georgia, USA.
  • Department of Medicine, Augusta University, Augusta, Georgia, USA.

ORCID-Profile: Xingming Shi

Förderung

  • NIA NIH HHS
  • NIH HHS
  • National Institute on Aging
  • National Institutes of Health

Zitieren

APA

Shi, X., Ding, K., Rosario, R., Ajith, A., Su, Y., Shaw, S., McGee-Lawrence, M., Lu, X. Y., Horuzsko, A., & Isales, C. M. (2024). Effects of Systemic Peroxisome Proliferator-Activated Receptor Gamma Inhibition on Bone and Immune Cells in Aged Female Mice. The Journals of Gerontology: Series A. https://doi.org/10.1093/gerona/glad247

Vancouver

Shi X, Ding K, Rosario R, Ajith A, Su Y, Shaw S, et al. Effects of Systemic Peroxisome Proliferator-Activated Receptor Gamma Inhibition on Bone and Immune Cells in Aged Female Mice. The Journals of Gerontology: Series A. 2024. doi:10.1093/gerona/glad247

BibTeX
@article{Shi2024,
  author = {Shi, Xingming and Ding, Kehong and Rosario, Raysa and Ajith, Ashwin and Su, Yun and Shaw, Sean and McGee-Lawrence, Meghan and Lu, Xin-Yun and Horuzsko, Anatolij and Isales, Carlos M},
  title = {Effects of Systemic Peroxisome Proliferator-Activated Receptor Gamma Inhibition on Bone and Immune Cells in Aged Female Mice},
  journal = {The Journals of Gerontology: Series A},
  year = {2024},
  doi = {10.1093/gerona/glad247}
}
Kostenlos starten →